Daniel Louis Yokell, Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluorine Radioisotopes | 5 | 2021 | 442 | 0.690 |
Why?
|
| Radiopharmaceuticals | 8 | 2022 | 2645 | 0.500 |
Why?
|
| Carbolines | 4 | 2016 | 265 | 0.450 |
Why?
|
| Misonidazole | 1 | 2012 | 34 | 0.430 |
Why?
|
| Positron-Emission Tomography | 10 | 2022 | 6234 | 0.350 |
Why?
|
| Microfluidics | 2 | 2014 | 662 | 0.300 |
Why?
|
| Isoquinolines | 2 | 2019 | 367 | 0.280 |
Why?
|
| tau Proteins | 4 | 2019 | 1868 | 0.240 |
Why?
|
| Oxygen | 2 | 2015 | 4189 | 0.200 |
Why?
|
| Fragile X Syndrome | 1 | 2021 | 115 | 0.180 |
Why?
|
| Radiochemistry | 2 | 2017 | 55 | 0.180 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 354 | 0.180 |
Why?
|
| Radiometry | 1 | 2022 | 800 | 0.150 |
Why?
|
| Gallium Radioisotopes | 2 | 2013 | 178 | 0.140 |
Why?
|
| Onium Compounds | 1 | 2015 | 31 | 0.130 |
Why?
|
| Neurofibrillary Tangles | 1 | 2017 | 439 | 0.120 |
Why?
|
| Silicates | 1 | 2013 | 42 | 0.110 |
Why?
|
| Glass | 1 | 2013 | 114 | 0.110 |
Why?
|
| Aminopyridines | 1 | 2017 | 542 | 0.110 |
Why?
|
| Octreotide | 1 | 2013 | 145 | 0.110 |
Why?
|
| Receptors, Somatostatin | 1 | 2013 | 129 | 0.110 |
Why?
|
| Iodine | 1 | 2015 | 286 | 0.110 |
Why?
|
| Boron Compounds | 1 | 2013 | 178 | 0.100 |
Why?
|
| Quinolines | 1 | 2017 | 732 | 0.100 |
Why?
|
| Isotope Labeling | 1 | 2013 | 406 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 319 | 0.100 |
Why?
|
| Nitriles | 1 | 2015 | 956 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2016 | 828 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 594 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8037 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2022 | 2327 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 1524 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 5708 | 0.060 |
Why?
|
| Automation | 2 | 2017 | 584 | 0.060 |
Why?
|
| Pyridines | 1 | 2015 | 2825 | 0.060 |
Why?
|
| Peptides | 1 | 2013 | 4409 | 0.050 |
Why?
|
| Brain | 3 | 2021 | 26385 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 117 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10481 | 0.040 |
Why?
|
| Halogenation | 1 | 2017 | 41 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2020 | 1137 | 0.040 |
Why?
|
| Aging | 1 | 2015 | 8664 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2016 | 380 | 0.030 |
Why?
|
| Quality Control | 1 | 2017 | 841 | 0.030 |
Why?
|
| Chemical Fractionation | 1 | 2013 | 65 | 0.030 |
Why?
|
| Electrons | 1 | 2015 | 268 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 682 | 0.030 |
Why?
|
| Solubility | 1 | 2013 | 1085 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2015 | 986 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 1572 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2031 | 0.020 |
Why?
|
| Thiazoles | 1 | 2015 | 1483 | 0.020 |
Why?
|
| Temperature | 1 | 2015 | 2206 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7799 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2015 | 1670 | 0.020 |
Why?
|
| Myocardium | 1 | 2020 | 4776 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3589 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3689 | 0.020 |
Why?
|
| Humans | 10 | 2022 | 744343 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 6314 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3557 | 0.020 |
Why?
|
| Middle Aged | 4 | 2021 | 213383 | 0.020 |
Why?
|
| Male | 5 | 2022 | 350118 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12072 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6196 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 3587 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 163280 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 214055 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 24260 | 0.010 |
Why?
|
| Female | 3 | 2022 | 380194 | 0.010 |
Why?
|
| Animals | 2 | 2022 | 168757 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 29063 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 63114 | 0.000 |
Why?
|
| Mice | 1 | 2013 | 81183 | 0.000 |
Why?
|